Main Article Content
Abstract
Background
Drug utilization research is to facilitate the rational use of drugs in populations. Chronic obstructive pulmonary disease (COPD) requires extensive treatment with multiple drug therapy. Due to its increasing prevalence and complications, it is rapidly becoming one of the world’s most serious health issues. It is necessary to treat the disease at the earliest with proper monitoring and evaluation of the therapy to prevent further progression and associated complications.The present study was undertaken to understand the prescription pattern of patients diagnosed with COPD in a tertiary care hospital, Mahavir institute of medical sciences.
Methods
A prospective, observational study was conducted over a period of 6 months, among the 100 patients admitted in patient department of medicine ward. Data was collected from COPD Patients admission records. Parameters likedemographic profile, common associated diseases, WHO core drug indicators and commonly prescribed drugs wereassessed from the prescriptions.
Results
It was found that the prevalence of COPD was higher in Grade III patients (78%), followed by 12% in Grade II and 10% in Grade I. Grading was done based on the socioeconomic status. Males (68%) were more affected than females (32%) and among the patients affected 32 were alcoholics and 37 were smokers.
Conclusion
In present study corticosteroids, methyl xanthenes and antibiotics were more used when compared with other drugs. Majority of the prescriptions were in accordance with Global initiative for chronic obstructive lung disease (GOLD) criteria recommendations
Keywords
Article Details
How to Cite
References
-
[1]. World Health Organisation. Chronic obstructive pulmonary disease (COPD). Geneva. World Health
Organisation. Available at:http://www.who.int/topics/chronic_obstructive_pulmonary_disease/en/. 2016.
[2]. Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2017 global strategy for the
diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2017, 31-36. Available
at: http://goldcopd.org/gold-2017- global-strategy-diagnosis-management.
[3]. Global initiative for chronic obstructive pulmonary disease updated 2019. Available from: http://
www.goldcopd.org
[4]. World Health Organisation. Rational use of medicines. Geneva. World Health Organisation; 2016.
Available at: http://apps.who.int/medicinedocs/en/d/Js6160e/10.ht ml. /.
[5]. Institute for Health and Clinical Excellence, chronic obstructive pulmonary disease, management of
chronic obstructive pulmonary disease in adults in primary and secondary care (partial update), NICE 2010.
Available from: http://www.nice.org.uk/.
[6]. Chaturvedi R, Muzammil K, Singh N, Davey S, Singh JV. Prevalence of COPD in rural population,
Muzaffarnagar. Indian J Community Heal. 27(4), 2015, 468-72
[7]. Ttritathi KD, Drugs for cough and Bronchial Asthma, KD Tripahti, Essentials of medical pharmacology, 8
Edition, Jaypee brothers medical publishers. 2019, 241-53
References
Organisation. Available at:http://www.who.int/topics/chronic_obstructive_pulmonary_disease/en/. 2016.
[2]. Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2017 global strategy for the
diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2017, 31-36. Available
at: http://goldcopd.org/gold-2017- global-strategy-diagnosis-management.
[3]. Global initiative for chronic obstructive pulmonary disease updated 2019. Available from: http://
www.goldcopd.org
[4]. World Health Organisation. Rational use of medicines. Geneva. World Health Organisation; 2016.
Available at: http://apps.who.int/medicinedocs/en/d/Js6160e/10.ht ml. /.
[5]. Institute for Health and Clinical Excellence, chronic obstructive pulmonary disease, management of
chronic obstructive pulmonary disease in adults in primary and secondary care (partial update), NICE 2010.
Available from: http://www.nice.org.uk/.
[6]. Chaturvedi R, Muzammil K, Singh N, Davey S, Singh JV. Prevalence of COPD in rural population,
Muzaffarnagar. Indian J Community Heal. 27(4), 2015, 468-72
[7]. Ttritathi KD, Drugs for cough and Bronchial Asthma, KD Tripahti, Essentials of medical pharmacology, 8
Edition, Jaypee brothers medical publishers. 2019, 241-53